Asia Pacific Feed Antibiotics Market Industry: Market Size & Forecast 2026

Feed antibiotics are widely used in Asia Pacific to support the health and productivity of poultry, swine, cattle, and aquaculture species, particularly in countries with large-scale commercial farming. The market is valued at approximately USD 17.07 billion in 2025 and is forecast to expand at a compound annual growth rate of about 5.39%. Asia Pacific represents one of the largest regional feed antibiotic markets globally due to its livestock population, expanding aquaculture sector, and rising domestic demand for animal protein.

• •Estimated market value of USD 17.07 billion in 2025.
• •Forecast CAGR of approximately 5.39%.
• •Region spans major livestock producers including China, India, Vietnam, Thailand, Indonesia, Japan, and Australia.

Rising per-capita consumption of meat, milk, eggs, and seafood is the principal demand-side driver, pushing producers to scale up output and protect herd health. Industrialization of livestock and aquaculture operations, combined with persistent risks from bacterial diseases such as avian influenza, foot-and-mouth disease, and aquaculture pathogens, sustains routine use of prophylactic and growth-promoting antibiotics. Greater adoption of commercial compound feed in emerging Asia Pacific economies further supports volume growth.

• •Rising protein consumption across developing Asia Pacific economies.
• •Ongoing disease pressure in poultry, swine, and aquaculture.
• •Shift from traditional farming toward commercial compound feed.

The market is segmented by antibiotic class into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, and others, and by livestock type into poultry, swine, ruminants, aquaculture, and others. Tetracyclines and penicillins historically dominate volume share due to broad-spectrum efficacy and lower cost, while aquaculture applications represent one of the fastest-growing sub-segments. China and India account for the largest shares, followed by Southeast Asian producers such as Vietnam, Thailand, and Indonesia, with Japan, South Korea, and Australia showing more mature, regulation-heavy markets.

• •Tetracyclines and penicillins remain the leading antibiotic classes by volume.
• •Poultry and swine are the largest livestock segments; aquaculture is expanding rapidly.
• •China and India lead regional consumption; Southeast Asia is a high-growth area.

What are the recent trends and outlook?

A clear trend across Asia Pacific is the gradual tightening of regulations on antibiotic growth promoters, with the European Union-style ban already implemented in some markets and partial restrictions expanding in China, India, and Southeast Asia. Producers are responding by investing in improved farm biosecurity, vaccination programs, and non-antibiotic feed additives such as probiotics, prebiotics, enzymes, and organic acids as substitutes or complements. Despite regulatory pressure, therapeutic and metaphylactic use of antibiotics is expected to keep volumes growing, supporting a continued market expansion through the early 2030s at a pace broadly consistent with current growth rates.

• •Regulatory restrictions on growth-promoting antibiotics are expanding across the region.
• •Rising adoption of probiotics, prebiotics, enzymes, and acidifiers as complementary additives.
• •Demand for therapeutic antibiotics and aquaculture applications continues to support overall market growth.